Bionano Genomics, Inc.
USD1.26
+0.01 (+0.80%)
CEO
Robert Erik Holmlin
IPO Date
2018-08-21
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$1.24
Prev. Close
$1.25
Day Low
$1.23
Day High
$1.27
52W Low
$1.06
52W High
$5.50
Market Cap
$0.00B
Volume
0.15M
| 9,149 |
| $1.19 |
| 14 May 2026 | Vuori Kristiina MD | director | A-Award | Acquired | 9,149 | $1.19 |
| 14 May 2026 | TWOMEY CHRISTOPHER J | director | A-Award | Acquired | 9,149 | $1.19 |
| 14 May 2026 | BARKER DAVID L | director | A-Award | Acquired | 9,149 | $1.19 |
| 18 Feb 2026 | Chaubey Alka | CHIEF MEDICAL OFFICER | F-InKind | Disposed | 18 | $1.10 |
| 18 Feb 2026 | Adamchak Mark | Principal Accounting Officer | F-InKind | Disposed | 3 | $1.10 |
| 18 Feb 2026 | Dixon Jonathan V. | GENERAL COUNSEL | F-InKind | Disposed | 6 | $1.10 |
| 18 Feb 2026 | OLDAKOWSKI MARK | CHIEF OPERATING OFFICER | F-InKind | Disposed | 20 | $1.10 |
| 18 Feb 2026 | Holmlin R. Erik | director, officer: PRESIDENT AND CEO | F-InKind | Disposed | 51 | $1.10 |